Charles B. Lobetti III - 31 Jul 2024 Form 5 Insider Report for Healthcare Integrated Technologies Inc. (SSGC)

Role
Chief Financial Officer
Signature
/s/ Charles B. Lobetti, III
Issuer symbol
SSGC
Transactions as of
31 Jul 2024
Net transactions value
+$397,876
Form type
5
Filing time
02 Aug 2024, 16:05:28 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HITC Common Stock Award $30,000 +500,000 $0.0600* 500,000 16 Jul 2020 Direct F1
transaction HITC Common Stock Award $165,000 +1,500,000 $0.1100 1,500,000 31 Jul 2023 Direct F2
transaction HITC Common Stock Award $202,876 +2,028,764 $0.1000 2,028,764 31 Jul 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HITC Holdings 150,000 31 Jul 2024 Common Stock 150,000 $0.1500 Direct F4
holding HITC Holdings 150,000 31 Jul 2024 Common Stock 150,000 $0.1500 Direct F4
holding HITC Holdings 150,000 31 Jul 2024 Common Stock 150,000 $0.1500 Direct F4
holding HITC Holdings 150,000 31 Jul 2024 Common Stock 150,000 $0.1500 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 16, 2020, the Board of Directors of the issuer awarded the Reporting Person 600,000 shares of restricted common stock, all of which are currently vested. The shares vested as follows: 7/16/20 - 200,000 shares; 7/16/21 - 100,000 shares; 7/16/22 - 100,000 shares; and 7/16/23 - 100,000 shares.
F2 On July 31, 2023, the Board of Directors of the issuer approved the issuance of 1,500,000 shares of common stock to the Reporting Person as partial payment for compensation owed to him as of July 31, 2023 under his Employment Agreement dated October 8, 2019.
F3 On July 31, 2024, the Board of Directors of the issuer approved the issuance of 2,028,764 shares of common stock to the Reporting Person as partial payment for compensation owed to him as of July 31, 2024 under his Employment Agreement dated January 31, 2024.
F4 On October 8, 2019, the Reporting Person was appointed Chief Financial Officer of the issuer. Upon execution of an Employment Agreement dated on such date, the Reporting Person was awarded 600,000 common stock purchase options, all of which are currently vested. The common stock purchase options vested as follows: 10/8/19 - 150,000 shares; 10/8/20 - 150,000 shares; 10/8/21 - 150,000 shares; and 10/8/22 - 150,000.